GOVERNMENT COUNSEL, LLC

Lobbying for APOTEX CORPORATION · Generic pharmaceutical manufacturer

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate · $20,000.00 income · posted Apr 17, 2026

Lobbying activity 1

Manufacturing

Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.